Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma [Medical Sciences]
Neuroblastoma is a childhood cancer that is fatal in almost half of patients despite intense multimodality treatment. This cancer is derived from neuroendocrine tissue located in the sympathetic nervous system. Glypican-2 (GPC2) is a cell surface heparan sulfate proteoglycan that is important for neuronal cell adhesion and neurite outgrowth. In...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Nan Li, Haiying Fu, Stephen M. Hewitt, Dimiter S. Dimitrov, Mitchell Ho Tags: PNAS Plus Source Type: research
More News: Academies | Brain | Cancer | Cancer & Oncology | Childhood Cancer | Neuroblastoma | Neurology | Reflex Sympathetic Dystrophy